Home Health and Hospice Activity Dips After Busy 2021; Expect a Bounce Back Next Three Quarters

The first quarter of 2022 delivered twenty-eight reported home health and hospice acquisitions, coming down from peaks levels to end the past year. However, Q1 has historically brought lower M&A levels, and we expect deal volume to rebound throughout the year.


Andy Snyder, a FOCUS Managing Director, has ten years of consulting, management, and M&A advisory experience among various healthcare positions. He has significant experience advising physicians in medical practice and surgery center transactions – including the specialties of ophthalmology, gastroenterology, dermatology, and orthopedics. His current practice includes healthcare provider services, home health and hospice, and behavioral health.